TransMedics (TMDX) Revenue (2018 - 2026)

TransMedics' Revenue history runs 9 years deep, the most recent figure standing at $173.9 million for Q1 2026.

• In Q1 2026, Revenue rose 21.18% year-over-year to $173.9 million; the TTM figure through Mar 2026 stood at $635.9 million (up 30.24% YoY), while the FY2025 annual figure was $605.5 million, up 37.13% from the prior year.
• Revenue was $173.9 million for Q1 2026 at TransMedics, up from $160.8 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $173.9 million in Q1 2026 to a low of $15.9 million in Q1 2022.
• Historically, Revenue has averaged $91.5 million across 5 years, with a median of $96.8 million in 2024.
• The sharpest annual moves came in 2022 and 2026: Revenue jumped 374.47% in 2022, then advanced 21.18% in 2026.
• A 5-year view of Revenue shows it stood at $31.4 million in 2022, then jumped by 158.72% to $81.2 million in 2023, then soared by 49.83% to $121.6 million in 2024, then jumped by 32.18% to $160.8 million in 2025, then advanced by 8.19% to $173.9 million in 2026.
• The last three Revenue figures came in at $173.9 million (Q1 2026), $160.8 million (Q4 2025), and $143.8 million (Q3 2025), per Business Quant data.